Header Logo

Connection

Daniel Schultz to Antineoplastic Agents

This is a "connection" page, showing publications Daniel Schultz has written about Antineoplastic Agents.
Connection Strength

0.725
  1. Carbohydrate-Small Molecule Hybrids as Lead Compounds Targeting IL-6 Signaling. Molecules. 2023 Jan 09; 28(2).
    View in: PubMed
    Score: 0.566
  2. Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. J Med Chem. 2024 Sep 26; 67(18):16270-16295.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.